Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case report: post-transfusion purpura

J Gonzalez1, J Schwartz, G Gerstein

  • 1Morristown Memorial Hospital, NJ 07962-1956, USA.

New Jersey Medicine : the Journal of the Medical Society of New Jersey
|February 1, 1996
PubMed
Summary

Post-transfusion purpura (PTP) is a rare condition causing severe low platelets after a blood transfusion. This case highlights plasmapheresis as an effective treatment for this uncommon disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An exploration of plastic deformation dependence of cell viability and adhesion in metallic implant materials.

Journal of the mechanical behavior of biomedical materials·2016
Same author

Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.

The British journal of dermatology·2009
Same author

The surgical correction of protuberant ears.

Skin therapy letter·2005
Same author

Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.

Bone marrow transplantation·2003
Same author

Dermatologic surgery into the next millennium, IV.

Cutis·2001
Same author

Dermatologic surgery into the next millennium, Part III.

Cutis·2001

Area of Science:

  • Hematology
  • Immunology

Background:

  • Post-transfusion purpura (PTP) is a rare immune-mediated complication following blood product transfusion.
  • It is characterized by severe thrombocytopenia occurring approximately 5-10 days post-transfusion.

Observation:

  • A case of PTP is presented in a patient who developed severe thrombocytopenia after a blood transfusion.
  • The patient was treated with plasmapheresis.

Findings:

  • Plasmapheresis was an effective therapeutic intervention for the patient diagnosed with post-transfusion purpura.
  • This underscores the treatable nature of PTP despite its rarity.

Implications:

  • The successful use of plasmapheresis in this case expands treatment options for post-transfusion purpura.
  • Increased awareness of PTP and its management is crucial for clinicians managing transfusion recipients.

Related Experiment Videos